Skip to search formSkip to main contentSkip to account menu

tafluprost

Known as: 1-methylethyl (5Z)-7-((1R,2R, 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy -1-butenyl)-3,5-dihydroxycyclopentyl)-5-heptenoate, Isopropyl (5z)-7-((1R,2R,3R,5S)-2-((1E)-3,3-Difluoro-4-Phenoxybut-1-Enyl)-3,5-Dihydroxycyclopentyl)Hept-5-Enoate 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (2)

AFP-168Zioptan
Prostaglandinsanalogs & derivatives

Broader (1)

Prostaglandins F

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Effect of preservative‐free tafluprost on intraocular pressure, pupil diameter, and anterior segment structures in normal canine eyes
OBJECTIVE This study was designed to evaluate the changes in intraocular pressure (IOP), pupil diameter (PD), and anterior… 
2017
2017
Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence
IntroductionThe aim of this study was to investigate the long-term intraocular pressure (IOP)-lowering effect and safety of… 
2015
2015
Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative‐free tafluprost
Benzalkonium chloride (BAK) is a controversial ophthalmic preservative because of its prominent side‐effect profile. In this… 
2013
2013
Effect of Tafluprost 0.0015% on Central Corneal Thickness in Patients With Primary Open-angle Glaucoma
Abstract Purpose: To evaluate the effect of tafluprost on the central corneal thickness (CCT) in patients with primary open-angle… 
2010
2010
Effects of repeated administrations of tafluprost, latanoprost, and travoprost on optic nerve head blood flow in conscious normal rabbits.
PURPOSE The aim of this study was to evaluate and compare the effects of repeated administrations of three prostaglandin F(2alpha… 
2010
2010
Effects of topical phenylephrine and tafluprost on optic nerve head circulation in monkeys with unilateral experimental glaucoma.
PURPOSE To compare the effects of a topical alpha agonist (vasoconstrictor) and a prostaglandin receptor (FP) agonist… 
2010
2010
Twenty-four-hour ocular hypotensive effects of 0.0015% tafluprost and 0.005% latanoprost in healthy subjects
PurposeTo compare the intraocular pressure (IOP) reduction over 24 h achieved with tafluprost (0.0015%) with that achieved with… 
2010
2010
[Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy].
Optimization of benzalkonium chloride (alkyl dimethylbenzylammonium chloride: BAK) concentration as preservative in 0.0015… 
Review
2006
Review
2006
Prostanoids in the therapy of glaucoma.
Elevated intraocular pressure (IOP) is one of the most important risk factors for the development of glaucoma, which is a… 
Highly Cited
2005
Highly Cited
2005
Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
PURPOSE To establish a mouse model for the pharmacological analysis of antiglaucoma drugs, considering the effect of variations… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)